ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Receive US$35M Commitment and Additional US$50M
|
|
10bagga
|
32 |
13K |
1 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
32
|
13K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Receive US$35M Commitment and Additional US$50M
|
|
10bagga
|
32 |
13K |
1 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
32
|
13K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Proposed EGM and VOTE THEM OUT
|
|
10bagga
|
12 |
3.3K |
0 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
12
|
3.3K
|
0
|
|
ASX - By Stock
|
ZNO |
Re:
Ann: Half Year Results Presentation
|
|
10bagga
|
25 |
11K |
4 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
25
|
11K
|
4
|
|
ASX - By Stock
|
ALO |
Re:
Ann: Alloggio 1H FY22 Management Presentation
|
|
10bagga
|
6 |
3.2K |
2 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
6
|
3.2K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron planned Acquisition of R&D Vaccine Company
|
|
10bagga
|
115 |
32K |
1 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
115
|
32K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Preliminary Final Report
|
|
10bagga
|
30 |
10K |
4 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
30
|
10K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE well tolerated in multiple dose clinical study
|
|
10bagga
|
24 |
6.5K |
0 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
24
|
6.5K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Market Update
|
|
10bagga
|
179 |
66K |
3 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
179
|
66K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Market Update
|
|
10bagga
|
179 |
66K |
1 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
179
|
66K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: TGA infringement notices for alleged advertising
|
|
10bagga
|
131 |
32K |
3 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
131
|
32K
|
3
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Concurrent Placement with Entitlement Offer to be Conducted
|
|
10bagga
|
2 |
1.7K |
1 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
2
|
1.7K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
10bagga
|
438 |
119K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
438
|
119K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
10bagga
|
438 |
119K |
2 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
438
|
119K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
10bagga
|
438 |
119K |
5 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
438
|
119K
|
5
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Ramelius Offer Now at 50.5% and Unconditional
|
|
10bagga
|
14 |
11K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
14
|
11K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4D & Half Year Report
|
|
10bagga
|
65 |
1.8M |
4 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
65
|
1.8M
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4D & Half Year Report
|
|
10bagga
|
65 |
1.8M |
0 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
65
|
1.8M
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4D & Half Year Report
|
|
10bagga
|
65 |
1.8M |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
65
|
1.8M
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appointment of US-based Consultant Medical Director
|
|
10bagga
|
43 |
407K |
7 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
43
|
407K
|
7
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Retraction of Statements and Clarification
|
|
10bagga
|
177 |
177K |
1 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
177
|
177K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Results in DMD unlock value creation potential of ATL1102
|
|
10bagga
|
93 |
54K |
2 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
93
|
54K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Trading Halt
|
|
10bagga
|
11 |
6.4K |
3 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
11
|
6.4K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT-Corona? Nothing to see- Keep Dreaming
|
|
10bagga
|
64 |
43K |
3 |
10/02/20 |
10/02/20 |
ASX - By Stock
|
64
|
43K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
For the 300 , Keep The Faith
|
|
10bagga
|
369 |
234K |
4 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
369
|
234K
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
10bagga
|
5.9K |
2.2M |
0 |
05/02/20 |
05/02/20 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
10bagga
|
5.9K |
2.2M |
0 |
05/02/20 |
05/02/20 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
10bagga
|
5.9K |
2.2M |
9 |
04/02/20 |
04/02/20 |
Charts
|
5.9K
|
2.2M
|
9
|
|
ASX - By Stock
|
PAA |
Re:
For the 300 , Keep The Faith
|
|
10bagga
|
369 |
234K |
2 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
369
|
234K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
For the 300 , Keep The Faith
|
|
10bagga
|
369 |
234K |
4 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
369
|
234K
|
4
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 4C - quarterly
|
|
10bagga
|
6 |
9.0K |
1 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
6
|
9.0K
|
1
|
|
ASX - By Stock
|
NCZ |
Re:
Ann: Quarterly Cashflow Report
|
|
10bagga
|
19 |
30K |
2 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
19
|
30K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
For the 300 , Keep The Faith
|
|
10bagga
|
369 |
234K |
2 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
369
|
234K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
For the 300 , Keep The Faith
|
|
10bagga
|
369 |
234K |
3 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
369
|
234K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
10bagga
|
67 |
28K |
2 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
67
|
28K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
10bagga
|
67 |
28K |
3 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
67
|
28K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Coronavirus and cortisol
|
|
10bagga
|
7 |
16K |
5 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
7
|
16K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
10bagga
|
67 |
28K |
2 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
67
|
28K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
10bagga
|
67 |
28K |
5 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
67
|
28K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Letter to the Board of Directors , Pharmaust
|
|
10bagga
|
20 |
10K |
2 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
20
|
10K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Letter to the Board of Directors , Pharmaust
|
|
10bagga
|
20 |
10K |
0 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
20
|
10K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Letter to the Board of Directors , Pharmaust
|
|
10bagga
|
20 |
10K |
2 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
20
|
10K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Letter to the Board of Directors , Pharmaust
|
|
10bagga
|
20 |
10K |
2 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
20
|
10K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Letter to the Board of Directors , Pharmaust
|
|
10bagga
|
20 |
10K |
5 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
20
|
10K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
THE CLASSIC BOT TRADER
|
|
10bagga
|
67 |
38K |
4 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
67
|
38K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
THE CLASSIC BOT TRADER
|
|
10bagga
|
67 |
38K |
4 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
67
|
38K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Top 20 30 November 2019
|
|
10bagga
|
4 |
3.0K |
5 |
13/01/20 |
13/01/20 |
ASX - By Stock
|
4
|
3.0K
|
5
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
10bagga
|
932 |
1.1M |
0 |
12/01/20 |
12/01/20 |
Charts
|
932
|
1.1M
|
0
|
|
ASX - By Stock
|
RCE |
Re:
when is the phase 1 trial scheduled to start
|
|
10bagga
|
91 |
35K |
1 |
09/01/20 |
09/01/20 |
ASX - By Stock
|
91
|
35K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
GOT TO LOVE AN OVERSELL
|
|
10bagga
|
33 |
13K |
3 |
09/01/20 |
09/01/20 |
ASX - By Stock
|
33
|
13K
|
3
|
|